Iguratimod - Simcere

Drug Profile

Iguratimod - Simcere

Alternative Names: Iremod

Latest Information Update: 07 May 2012

Price : $50

At a glance

  • Originator Simcere Pharmaceutical Group
  • Class Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Benzopyrans; Chromones; Small molecules; Sulfonamides
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors; Cytokine inhibitors; Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Rheumatoid arthritis

Most Recent Events

  • 08 Jan 2012 Launched for Rheumatoid arthritis in China (PO)
  • 25 Aug 2011 Registered for Rheumatoid arthritis in China (PO)
  • 25 Aug 2011 Registered for Osteoarthritis in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top